MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance
under at - the - market...
$2,303K
Tax credit
receivable
$1,612K
Net cash provided by
financing activities
$3,866K
Canceled cashflow
$49K
Net decrease in cash
and cash...
$1,374K
Canceled cashflow
$2,492K
Payment of loans payable
-$49K
Prepaid expenses and
other current assets
-$428K
Non-cash lease expense
$143K
Stock-based compensation
$135K
Change in fair value of
contingent consideration
$27K
Depreciation
$24K
Net cash used in
operating activities
-$2,456K
Effects of exchange rate
changes on cash and cash...
-$36K
Canceled cashflow
$757K
Net loss
-$2,044K
Deferred research and
development tax credit
-$417K
Accounts payable
-$397K
Accrued employee
benefits
-$172K
Operating lease liability
-$156K
Accrued expenses
-$27K
Back
Back
Cash Flow
Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX)
source: myfinsight.com